Cart
sales@molnova.com
Ethyl icosanoate
CAS No. 18281-05-5
Ethyl icosanoate( —— )
Catalog No. M37493 CAS No. 18281-05-5
Ethyl icosanoate (Ethyl arachidate) is a compound extracted from the rectal glands of the female B. correcta.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEthyl icosanoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEthyl icosanoate (Ethyl arachidate) is a compound extracted from the rectal glands of the female B. correcta.
-
DescriptionEthyl icosanoate is an ester, which is formed by the esterification of long-chain straight-chain fatty acids, eicosanoic acid and ethanol. The compound has a fruity, waxy smell and is commonly used as a flavoring in foods such as baked goods, candy and beverages. It is also used as a fragrance ingredient in personal care products and as a lubricant or plasticizer in various industrial applications. In addition, Ethyl icosanoate can be used as a starting material for the synthesis of other organic compounds.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18281-05-5
-
Formula Weight340.58
-
Molecular FormulaC22H44O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCCCCCCCCCCCC(=O)OCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GAC0003A4
GAC0003A4 is a potent LXR inverse agonist with antitumor activity that inhibits the transcription of LXR proteins.GAC0003A4 degrades LXRβ proteins and inhibits the proliferation of PDAC cells in a dose-dependent manner.
-
1,1'-(4-CHLOROBUTYLI...
1,1'-(4-Chlorobutylidene)bis(4-fluorobenzene) is a derivative of Zerumbone with potential anti-tumor effects towards HeLa cancer cells.
-
VT104
VT104 is a potent and orally active YAP/TAZ inhibitor for cancer research. VT104 blocks palmitoylation of endogenous TEAD1 and TEAD3 proteins.
